Financement

Financeur: ALTHEUS THERAPEUTICS, INC

1 financements

données disponibles depuis 2013

2013

Preclinical Evaluation of Mesalazine Plus N-Acetylcysteine for The Treatment of Ulcerative Colitis (UC) Associated with Primary Sclerosing Cholangitis (PSC)